The contribution of the cingulate cortex: treating depressive symptoms in first-episode drug naïve schizophrenia

• Haoran Shen ^[1] ; Likun Ge ^[1] ; Bo Cao ^[2] ; Gao-Xia Wei ^[1] ; Xiangyang Zhang ^[1]
  1. [1] Chinese Academy of Sciences

     Chinese Academy of Sciences

     China

     
  2. [2] University of Alberta

     University of Alberta

     Canadá

     
• Localización: International journal of clinical and health psychology, ISSN 1697-2600, Vol. 23, Nº. 3, 2023, págs. 81-90
• Idioma: inglés
• DOI: 10.1016/j.ijchp.2023.100372
• Enlaces
  • Texto completo
• Resumen

  • Background Our previous study has shown the cingulate cortex abnormalities in first-episode drug naïve (FEDN) schizophrenia patients with comorbid depressive symptoms. However, it remains largely unknown whether antipsychotics may induce morphometric change in cingulate cortex and its relationship with depressive symptoms. The purpose of this study was to further clarify the important role of cingulate cortex in the treatment on depressive symptoms in FEDN schizophrenia patients.

    Method In this study, 42 FEDN schizophrenia patients were assigned into depressed patients group (DP, n = 24) and non-depressed patients group (NDP, n = 18) measured by the 24-item Hamilton Depression Rating Scale (HAMD). Clinical assessments and anatomical images were obtained from all patients before and after 12-week treatment with risperidone.

    Results Although risperidone alleviated psychotic symptoms in all patients, depressive symptoms were decreased only in DP. Significant group by time interaction effects were found in the right rostral anterior cingulate cortex (rACC) and other subcortical regions in the left hemisphere. After risperidone treatment, the right rACC were increased in DP. Further, the increasing volume of right rACC was negatively associated with improvement in depressive symptoms.

    Conclusion These findings suggested that the abnormality of the rACC is the typical characteristics in schizophrenia with depressive symptoms. It's likely key region contributing to the neural mechanisms underlying the effects of risperidone treatment on depressive symptoms in schizophrenia.

• Referencias bibliográficas
  • Addington, D., Addington, J., & Patten, S. (1998). Depression in people with first-episode schizophrenia. The British Journal of Psychiatry,...
  • Alkomiet, H., Peter, F., Thomas, W., Jeffrey, L., Birte, G., F, G. W., Florence, T., & Hans-Jurgen, M (2012). World Federation of Societies...
  • Bernhard, R. (1997). Can risperidone be antidepressive and also inhibit aggression? Journal of Neuropsychiatry & Clinical Neurosciences,...
  • Buckley, P. F., Miller, B. J., Lehrer, D. S., & Castle, D. J. (2009). Psychiatric comorbidities and schizophrenia. Schizophrenia Bulletin,...
  • Ceskova, E. (2020). Pharmacological strategies for the management of comorbid depression and schizophrenia. Electronic, 1744–7666.
  • Chen, C.-H., Ridler, K., Suckling, J., Williams, S., Fu, C. H. Y., Merlo-Pich, E., & Bullmore, E. T. (2007). Brain imaging correlates...
  • Conley, R. R., Ascher-Svanum, H., Zhu, B., Faries, D. E., & Kinon, B. J. (2007). The burden of depressive symptoms in the long-term treatment...
  • Conley, R. R., & Mahmoud, R. (2001). A randomized double-blind study of risperidone and olanzapine in the treatment of schizophrenia or...
  • Dai, J., Du, X., Yin, G., Zhang, Y., Xia, H., Li, X., Cassidy, R., et al. (2017). Prevalence, demographic and clinical features of comorbid...
  • Desikan, R. S., S_egonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., et al. (2006). An automated labeling system for subdividing...
  • Dhana, Wolf, Martin, Klasen, Patrick, Eisner, Florian, D., Zepf, & Mikhail (2018). Central serotonin modulates neural responses to virtual...
  • Di Biase, M. A., Zhang, F., Lyall, A., Kubicki, M., Mandl, R. C. W., Sommer, I. E., & Pasternak, O. (2020). Neuroimaging auditory verbal...
  • Duhameau, B., Ferre, J.-C., Jannin, P., Gauvrit, J.-Y., Verin, M., Millet, B., & Drapier, D. (2010). Chronic and treatment-resistant depression:...
  • EN, N., Schnack, H. G., Koevoets, M., Cahn, W., Pol, H. E. H., & Kahn, R. S (2016). Trajectories of subcortical volume change in schizophrenia:...
  • Eggers, & Arnold, E (2013). A serotonin hypothesis of schizophrenia. Medical Hypotheses, 80(6), 791–794.
  • Fischl, B., Salat, D. H., Busa, E., Albert, M., & Dale, A. M. (2002). Whole brain segmentation: automated labeling of neuroanatomical...
  • Fornito, A., Yucel, M., Dean, B., Wood, S. J., & Pantelis, C. (2009). Anatomical abnormalities of the anterior cingulate cortex in schizophrenia:...
  • Gener, T., Tauste Campo, A., Alemany-Gonzalez, M., Nebot, P., Delgado-Sallent, C., Chanovas, J., & Victoria Puig, M. (2019). Serotonin...
  • Ghosh, A., Kaur, S., Shah, R., Oomer, F., Avasthi, A., Ahuja, C. K., et al. (2022). Surfacebased brain morphometry in schizophrenia vs. cannabis-induced...
  • Godlewska, B. R., Browning, M., Norbury, R., Igoumenou, A., Cowen, P. J., & Harmer, C. J. (2018). Predicting treatment response in depression:...
  • Goto, M., Yoshimura, R., Kakihara, S., Shinkai, K., Yamada, Y., Kaji, K., Ueda, N., & Nakamura, J. (2006). Risperidone in the treatment...
  • Hamilton, M. (1960). A Rating Scale for Depression. Journal of Neurology, Neurosurgery & Psychiatry, 23(1), 56–62.
  • Han, K. M., & Ham, B. J. (2021). How inflammation affects the brain in depression: A Review of functional and structural MRI studies....
  • Herniman, S. E., Phillips, L. J., Wood, S. J., Cotton, S. M., Liemburg, E. J., & Allott, K. A. (2021). Interrelationships between depressive...
  • Hertel, P., Sc, B., Nomikos, SchilstrM, B., Sc, M, Arborelius, L., Ph., D., & Svensson, T. H. (1997). Risperidone dose-dependently increases...
  • Karlidere, Uzun, & Balikci (2015). Depressive symptoms in first episode schizophrenia patients under treatment: One-year follow-up comparison...
  • Kasper, S., Montagnani, G., Trespi, G., & Fiorino, M. D. (2015). Treatment of depressive symptoms in patients with schizophrenia: a randomized,...
  • Kay, Fiszbein, & Opler (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia bulletin, 13(2).
  • Kjelby, E., Jørgensen, H. A., Kroken, R. A., Løberg, E.-M., & Johnsen, E. (2011). Antidepressive effectiveness of olanzapine, quetiapine,...
  • Knowland, D., Lilascharoen, V., Pacia, C. P., Shin, S., Wang, E. H.-J., & Lim, B. K. (2017). Distinct ventral pallidal neural populations...
  • Kohler, C., Swanson, C. L., Gur, R. C., Mozley, L. H., & Gur, R. E. (1998). Depression in schizophrenia: II. MRI and PET findings. Biological...
  • Lang, D. J., Kopala, L. C., Vandorpe, R. A., Rui, Q., Smith, G. N., Goghari, V. M., & Honer, W. G. (2001). An MRI study of basal ganglia...
  • Li, W., Yang, Y., An, F. R., Zhang, L., & Xiang, Y. T. (2020). Prevalence of comorbid depression in schizophrenia: a meta-analysis of...
  • Mann, S. L., Hazlett, E. A., Byne, W., Hof, P. R., Buchsbaum, M. S., Cohen, B. H., Goldstein, K. E., Haznedar, M. M., Mitsis, E. M., Siever,...
  • Martin-Reyes, M., Mendoza, R., Dominguez, M., Caballero, A., Marta Bravo, T., Diaz, T., Gerra, S., Ibanez, A., & Linares, A. R (2011)....
  • Mayberg, H. S. (2003). Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for...
  • McKenna, F. F., Miles, L., Babb, J. S., Goff, D. C., & Lazar, M. (2019). Diffusion kurtosis imaging of gray matter in schizophrenia. Cortex,...
  • Morris, L. S., Costi, S., Tan, A., Stern, E. R., Charney, D. S., & Murrough, J. W. (2020). Ketamine normalizes subgenual cingulate cortex...
  • Nelson, B. D., Bjorkquist, O. A., Olsen, E. K., & Herbener, E. S. (2015). Schizophrenia symptom and functional correlates of anterior...
  • Okada, N, F, M., Yamashita, F, Koshiyama, D, Yamamori, H, Ohi, K, Yasuda, Y, Fujimoto, M., et al. (2016). Abnormal asymmetries in subcortical...
  • Okada, N., Yahata, N., Koshiyama, D., Morita, K., Sawada, K., Kanata, S., et al. (2018). Abnormal asymmetries in subcortical brain volume...
  • Oleg, B., Fabienne, H., Andre, S., Renata, S., J, H. D., Laura, E., Anita, R.-R., Paolo, F.-P., G, H. C., E, L. U., Christina, A., & Stefan,...
  • Peuskens, J., Baelen, B. V., Smedt, C. D., & Lemmens, P. (2000). Effects of risperidone on affective symptoms in patients with schizophrenia....
  • Piet, O., Robin, E., Dana, N., Liezl, K., & Bonga, C. (2006). The relationships between depression and remission in first-episode psychosis....
  • Reuter, M., Schmansky, N. J., Rosas, H. D., & Fischl, B. (2012). Within-subject template estimation for unbiased longitudinal image analysis....
  • Roya, S., Susan, S., Reza, D., Shervin, A., & Akhoundpour, M. A. (2017). Efficacy of risperidone augmentation with ondansetron in the...
  • Schnack, H. G., van Haren, N. E. M., Nieuwenhuis, M., Pol, H. E. H., Cahn, W., & Kahn, R. S. (2016). Accelerated brain aging in schizophrenia:...
  • Seon-Cheol, P., Jae-Min, K., Tae-Youn, J., Min-Soo, L., Jung-Bum, K., Hyeon-Woo, Y., & Chon, P. Y. (2017). How many different symptom...
  • Simmons, A. N., Estibaliz, A., Lovero, K. L., Stein, M. B., & Paulus, M. P. (2009). Subchronic SSRI administration reduces insula response...
  • Smith, S. M., & Nichols, T. E. (2009). Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and...
  • Stevens, F. L., Hurley, R. A., & Taber, K. H. (2011). Anterior cingulate cortex: Unique role in cognition and emotion. The Journal of...
  • Touroutoglou, A., & Dickerson, B. C. (2019). Cingulate-centered large-scale networks: Normal functions, aging, and neurodegenerative disease...
  • Upthegrove, R., Marwaha, S., & Birchwood, M. (2017). Depression and schizophrenia: Cause, consequence, or trans-diagnostic issue? Schizophrenia...
  • Wei, G., Ge, L., Chen, L., Cao, B., & Zhang, X. (2020). Structural abnormalities of cingulate cortex in patients with first-episode drug-naïve...
  • Yang, W., Zhang, G., Jia, Q., Qian, Z. K., & Zhang, X. (2019). Prevalence and clinical profiles of comorbid anxiety in first episode and...
  • Zhang, Y. J., Shao, J. N., Wang, X. Y., Chen, Z. L., Liu, H. Y., Pei, C., Zhang, S. Q., Yao, Z. J., & Lu, Q. (2021). Functional impairment-based...